Inflammatory Markers to Inform Treatment of Asthma With Biologicals: FeNO Versus Blood Eosinophils

J Allergy Clin Immunol Pract. 2023 Apr;11(4):1221-1223. doi: 10.1016/j.jaip.2023.02.001.

Authors

Kjell Alving¹, William G Teague²

Affiliations

¹ Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
² Department of Pediatrics, Child Health Research Center, University of Virginia School of Medicine, Charlottesville, Va.

PMID: 37030927
DOI: 10.1016/j.jaip.2023.02.001

No abstract available

Publication types

Editorial
Comment

MeSH terms

Asthma* / drug therapy
Biological Products* / therapeutic use
Biomarkers
Breath Tests
Eosinophils
Exhalation
Humans
Leukocyte Count
Nitric Oxide

Substances

Biological Products
Nitric Oxide
Biomarkers